EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019

Caihua Liang, Aleksandra Polkowska-Kramek iD, Caroline Lade, Lea J Bayer, Robin Bruyndonckx, Bennet Huebbe, Worku Biyadgie Ewnetu iD, Pimnara Peerawaranun, Maribel Casas, Thao Mai Phuong Tran, Gordon Brestrich, Christof von Eiff und 3 weitere

Influenza and Other Respiratory Viruses · 2025

DOI: 10.1111/irv.70097 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Influenza and Other Respiratory Viruses, 2025. Verfasst von Caihua Liang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Inc, New York, New York, USA. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Hospitalization, Cardiovascular Diseases, Respiratory Tract Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

RSV incidence in adults is frequently underestimated due to non‐specific symptomatology, limited standard‐of‐care testing, and lower test sensitivity compared to infants. We conducted a retrospective observational study to estimate RSV‐attributable incidence of specific types of cardiorespiratory hospitalizations among adults in Germany between 2015 and 2019.

Methods

Information on hospitalizations and the number of people at risk of hospitalization (denominator) was gathered from a Statutory Health Insurance database. A quasi‐Poisson regression model accounting for periodic and aperiodic time trends and virus activity was fitted to estimate the RSV‐attributable incidence rate (IR) of four specific cardiovascular hospitalizations (arrhythmia, ischemic heart diseases, chronic heart failure exacerbations, and cerebrovascular diseases) and four specific respiratory hospitalizations (influenza/pneumonia, bronchitis/bronchiolitis, chronic lower respiratory tract diseases, and upper respiratory tract diseases).

Results

The estimated RSV‐attributable IRs of hospitalizations generally increased with age. Among estimated cardiovascular hospitalizations in adults aged ≥ 60 years, arrhythmia and ischemic heart diseases accounted for the highest incidence of RSV‐attributable events, followed by chronic heart failure exacerbation, with annual IR ranges of 157–260, 133–214, and 105–169 per 100,000 person‐years, respectively. The most frequent RSV‐attributable respiratory hospitalizations in adults aged ≥ 60 years were estimated for chronic lower respiratory tract diseases and bronchitis/bronchiolitis, with annual IR ranges of 103–168 and 77–122 per 100,000 person‐years, respectively.

Conclusions

RSV causes a considerable burden of respiratory and cardiovascular hospitalizations in adults in Germany, similar to other respiratory viruses (e.g., influenza and SARS‐CoV‐2). This highlights the need to implement effective prevention strategies, especially for older adults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsHospitalizationCardiovascular DiseasesRespiratory Tract InfectionsHumansGermanyMiddle AgedIncidenceRetrospective StudiesAdultAgedMaleFemaleYoung AdultRespiratory Syncytial Virus, HumanAged, 80 and overAdolescent

Stichwörter der Autor:innen

GermanyRSVcardiorespiratoryhospitalizationquasi‐Poissontime‐series modeling

Autor:innen und Institutionen

  • Pfizer Inc, New York, New York, USA.
  • P95 Epidemiology & Pharmacovigilance, Leuven, Belgium.
  • Pfizer Pharma GmbH, Berlin, Germany.
  • Pfizer Inc, Dublin, Ireland.
  • University Hospital, Medical Clinic I, Department of Respiratory Medicine, Goethe University Frankfurt, Frankfurt, Germany.

ORCID-Profile: Aleksandra Polkowska-Kramek, Worku Biyadgie Ewnetu

Förderung

  • Pfizer

Zitieren

APA

Liang, C., Polkowska-Kramek, A., Lade, C., Bayer, L. J., Bruyndonckx, R., Huebbe, B., Ewnetu, W. B., Peerawaranun, P., Casas, M., Tran, T. M. P., Brestrich, G., von Eiff, C., Gessner, B. D., Begier, E., & Rohde, G. (2025). Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019. Influenza and Other Respiratory Viruses. https://doi.org/10.1111/irv.70097

Vancouver

Liang C, Polkowska-Kramek A, Lade C, Bayer LJ, Bruyndonckx R, Huebbe B, et al. Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019. Influenza and Other Respiratory Viruses. 2025. doi:10.1111/irv.70097

BibTeX
@article{Liang2025,
  author = {Liang, Caihua and Polkowska-Kramek, Aleksandra and Lade, Caroline and Bayer, Lea J and Bruyndonckx, Robin and Huebbe, Bennet and Ewnetu, Worku Biyadgie and Peerawaranun, Pimnara and Casas, Maribel and Tran, Thao Mai Phuong and Brestrich, Gordon and von Eiff, Christof and Gessner, Bradford D and Begier, Elizabeth and Rohde, Gernot},
  title = {Estimated Incidence Rate of Specific Types of Cardiovascular and Respiratory Hospitalizations Attributable to Respiratory Syncytial Virus Among Adults in Germany Between 2015 and 2019},
  journal = {Influenza and Other Respiratory Viruses},
  year = {2025},
  doi = {10.1111/irv.70097}
}
Kostenlos starten →